Intrinsic Bioprobes Enters into a $1.27M Contract with the National Cancer Institute to Develop Multiplex Mass Spectrometric Immunoassays for Detection of Low Abundance Cancer Related Proteins
News Apr 01, 2009
The total cost of the two and a half years contract is $1,276,360, out of which $1,130,272 is Federal money provided by the NCI, and $146,088 is the contractor’s share provided by Intrinsic Bioprobes Inc. This contract is in support of NCI’s Clinical Proteomic Technologies for Cancer initiative to assess and apply proteomic technologies and data resources to solve critical problems in cancer research (http://proteomics.cancer.gov).
“The purpose of this contract is to stimulate the development of multiplex mass
spectrometric immunoassay for the detection of low abundance cancer related
proteins/peptides from bodily fluids” says Dobrin Nedelkov, Ph.D., the Scientific Director of Intrinsic Bioprobes. “The application of proteomics tools in clinical setting lags far behind their use in basic science and drug discovery. The multiplex mass spectrometric immunoassays will bridge that gap because they are highly specific and selective, have ultra-sensitive detection capabilities and broad dynamic range, and require limited sample preparation. The mass spectrometric aspect of the assays also enables singlestep detection of protein isoforms and their individual quantification, which is an important protein diversity aspect regularly overlooked in contemporary proteomics
approaches”, adds Nedelkov.
New Method to Separate Mirrored Molecules Could Lead to Safer DrugsNews
The Dionne lab is developing an optical filter to sort chiral molecules, which could lead to purer and safer drugs and agrichemicals.READ MORE
APC Protein Deletion Disrupts Cell Signalling and Could Cause AutismNews
Researchers show deletion of the protein APC in progenitor cells leads to massive disruption of brain development and a signaling cascade previously linked to genes associated with autism.READ MORE
SCIEX Receive Science and Technology Award at HUPO 2017News
Two researchers from SCIEX received the HUPO 2017 award at the 16th Human Proteome Organization World Congress in Dublin, Ireland.READ MORE